Suicide cancer gene therapy using pore-forming toxin, streptolysin O

Area of Science:

• Molecular biology
• Genetics
• Biochemistry

Background:

• Streptococcus pyogenes produces streptolysin O, a pore-forming toxin.
• Investigating novel therapeutic agents for cancer is crucial.

Purpose of the Study:

• To evaluate streptolysin O as a potential anticancer reagent.
• To determine the regions of streptolysin O critical for its cell-killing activity.

Main Methods:

• Cloning the streptolysin O gene from Streptococcus pyogenes.
• Transient transfection of 293T cells and assessment of cell death via LDH release and propidium iodide uptake.
• Biochemical analysis of streptolysin O protein variants with deletions in the N-terminal and C-terminal regions.
• Adenovirus-mediated delivery of streptolysin O into human cervical cancer xenografts in nude mice.

Main Results:

• Streptolysin O gene transfection induced rapid cell death (necrosis) in 293T cells.
• The C-terminal region, essential for cholesterol binding, was critical for cell-killing activity.
• Deletions up to 115 amino acids in the N-terminal region did not abolish cell-killing activity.
• Adenovirus-mediated streptolysin O delivery significantly reduced tumor size in a mouse model.

Conclusions:

• Streptolysin O exhibits potent anticancer activity through necrosis.
• The N-terminal region of streptolysin O is more tolerant to deletions than the C-terminal region.
• Pore-forming toxin genes, such as streptolysin O, represent a promising new class of suicide gene therapy reagents for cancer treatment.